Dominic J. Robinson

Erasmus MC — Netherlands

Medicine · Health Sciences

37h-index5.3kcitations209works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Photodynamic Therapy Research Studies(124), Nanoplatforms for cancer theranostics(77), Photoacoustic and Ultrasonic Imaging(44), Optical Imaging and Spectroscopy Techniques(39), Esophageal Cancer Research and Treatment(28)

Publications209 total

Rigid Autofluorescence Imaging as a Tool for Identifying Cholesteatoma During Otologic Surgery: Initial Ex Vivo Findings
Otolaryngology·2025Open Access
Molecular-Targeted Fluorescence Lymph Node Imaging Could Play a Clinical Role in the Surgical Setting: A Systematic Review
Cancers·2025· 2 citedOpen Access
Supplementary Fig. 4 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025Open Access
Data from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025Open Access
Supplementary Fig. 5 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025Open Access
Supplementary Fig. 2 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025Open Access
Supplementary Fig. 7 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025Open Access
Supplementary Fig. 6 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025Open Access
Integrin targeted photodynamic therapy in patient‐derived glioblastoma spheroids
Photochemistry and Photobiology·2025Open Access
Supplementary Fig. 3 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025Open Access
Supplementary Fig. 1 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025Open Access
Exploring Si-phthalocyanines with different valency for PSMA-targeted photodynamic therapy: Synthesis and preclinical validation
European Journal of Medicinal Chemistry·2025· 1 citedOpen Access
Optical PD-L1 imaging using ultrasound-guided quantitative fluorescence molecular endoscopy combined with durvalumab-680LT in locally advanced esophageal cancer patients
Endoscopy·2025
Enhancing early detection of esophageal neoplastic lesions: oral administration of bevacizumab-800CW and cetuximab-800CW for quantified fluorescence molecular endoscopy
Endoscopy·2025
Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
Molecular Cancer Therapeutics·2024· 5 citedOpen Access
Fluorescence detection of pituitary neuroendocrine tumour during endoscopic transsphenoidal surgery using bevacizumab-800CW: a non-randomised, non-blinded, single centre feasibility and dose finding trial [DEPARTURE trial]
European Journal of Nuclear Medicine and Molecular Imaging·2024· 4 citedOpen Access
Supplementary Table S1 from Ultrasound-Guided Quantitative Fluorescence Molecular Endoscopy for Monitoring Response in Patients with Esophageal Cancer Following Neoadjuvant Chemoradiotherapy
2024Open Access
Data from Ultrasound-Guided Quantitative Fluorescence Molecular Endoscopy for Monitoring Response in Patients with Esophageal Cancer Following Neoadjuvant Chemoradiotherapy
2024Open Access
Supplementary Figure S1 from Ultrasound-Guided Quantitative Fluorescence Molecular Endoscopy for Monitoring Response in Patients with Esophageal Cancer Following Neoadjuvant Chemoradiotherapy
2024Open Access
Supplementary Material S1 from Ultrasound-Guided Quantitative Fluorescence Molecular Endoscopy for Monitoring Response in Patients with Esophageal Cancer Following Neoadjuvant Chemoradiotherapy
2024Open Access
page 1 of 11Next →

Frequent Co-authors

Henricus J. C. M. Sterenborg(27), Henriëtte S. de Bruijn(21), Arjen Amelink(13), Willem M. Star(7), Mark R. Stringer(6), E Haas(6), H. A. Martino Neumann(6), Stephen C. Kanick(6), Ute A. Gamm(6), Matthijs D. Linssen(5), Wouter B. Nagengast(5), Gooitzen M. van Dam(5), Max J. H. Witjes(5), G.I. Stables(5), Sabrina Oliveira(4), Nynke van der Veen(4), Clemens W.G.M. Löwik(4), Annelies Jorritsma‐Smit(4), Paul M. Collins(4), A. van der Ploeg–van den Heuvel(4)